Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer

BACKGROUND: We evaluated topoisomerase I (TOPO1) expression in patients with small cell lung cancer (SCLC) and identified predictive factors for the efficacy of second‐line topotecan chemotherapy. METHODS: We retrospectively evaluated the records of SCLC patients treated in our department from Janua...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Chunxin, Liu, Xiuju, Zheng, Qiwen, Chen, Hanxiao, Yang, Xue, Zhong, Jia, Wang, Yuyan, Duan, Jianchun, Wang, Zhijie, Bai, Hua, Wu, Meina, Zhao, Jun, Wang, Jie, Wang, Ziping, An, Tongtong, Zhuo, Minglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119620/
https://www.ncbi.nlm.nih.gov/pubmed/30058109
http://dx.doi.org/10.1111/1759-7714.12819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119620/
https://www.ncbi.nlm.nih.gov/pubmed/30058109
http://dx.doi.org/10.1111/1759-7714.12819

Ejemplares similares